{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:48:19Z","timestamp":1792856899855,"version":"4.5.0"},"reference-count":79,"publisher":"Bentham Science Publishers Ltd.","issue":"16","funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Government of India","doi-asserted-by":"publisher","award":["SR\/WOS-A\/CS-126\/2016(G)"],"award-info":[{"award-number":["SR\/WOS-A\/CS-126\/2016(G)"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"DBT-RRSFP-SAHAJ project","doi-asserted-by":"publisher","award":["BT\/INF\/22\/SP44789\/2021"],"award-info":[{"award-number":["BT\/INF\/22\/SP44789\/2021"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["ACAMC"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Anthraquinones are well known for their wide spectrum of pharmacological properties. Anthraquinone\nantibiotics, such as doxorubicin, daunorubicin, epirubicin, and mitoxantrone, have long been used in the clinical\nmanagement of various tumors. However, their use is limited due to their toxicity effects, especially cardiomyopathy,\ndespite their pronounced therapeutic effects. In recent years, medicinal chemists have explored the possibility\nof modifying the anthraquinone ring appended with structurally diverse functionality in order to develop\nbetter chemotherapeutic agents with fewer adverse effects. The fused polycyclic structure of anthraquinone offers\nrigidity, planarity, and aromaticity, which helps in double helix DNA intercalation, disruption of G4 DNA, and\ninhibition of topoisomerase-II enzyme of cancer cells, making them suitable pharmacophore for anticancer drug\ndiscovery. Incorporation of suitable functional groups such as amino, hydroxyl, and their derivatives into anthraquinone\nrings can improve their interactions with biological targets involved in cancer progression. These subtle\nstructural changes produce newer anthraquinone derivatives with improved anticancer properties, increased potency,\nselectivity, and reduced toxicity, and can overcome multi-drug resistance. On the other hand, the molecular\nhybrids of the anthraquinone derivatives have been reported to act on multiple targets in cancer cells, as seen in\nthe case of clinical candidates like alectinib, midostaurin, tucatinib, belinostat, and dacinostat. Molecular hybrid\nhas given a new direction for anticancer drug development, which can produce bifunctional drug candidates with\nreduced toxicity. This review summarizes different structural modifications that have been made to the anthraquinone\nring in the last decade with the aim of bringing out potent yet toxicity-free anticancer agents.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0118715206374787250227064528","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:34:51Z","timestamp":1741048491000},"page":"1161-1174","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Redefining Anthraquinone-based Anticancer Drug Design through Subtle Chemical Modifications"],"prefix":"10.2174","volume":"25","author":[{"given":"Bijayashree","family":"Mishra","sequence":"first","affiliation":[{"name":"Department of Chemistry, Tripura University (A Central University), Suryamaninagar, 799022, Tripura (W), India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5432-8787","authenticated-orcid":true,"given":"Pratap Chandra","family":"Acharya","sequence":"additional","affiliation":[{"name":"Department of\nPharmacy, Drug Metabolomics Laboratory, Tripura University (A Central University), Suryamaninagar, 799022, Tripura (W), India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4870-5758","authenticated-orcid":true,"given":"Utpal Chandra","family":"De","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Tripura University (A Central University), Suryamaninagar, 799022, Tripura (W), India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/0041-008X(92)90273-U","volume":"112","author":"Monks T.J.","year":"1992","unstructured":"Monks T.J.; Hanzlik R.P.; Cohen G.M.; Ross D.; Graham D.G.; Quinone chemistry and toxicity. Toxicol Appl Pharmacol  1992,112(1),2-16","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/med.21391","volume":"36","author":"Malik E.M.","year":"2016","unstructured":"Malik E.M.; M\u00fcller C.E.; Anthraquinones as pharmacological tools and drugs. Med Res Rev  2016,36(4),705-748","journal-title":"Med Res Rev"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jare.2021.11.007","volume":"39","author":"Shakour Z.T.","year":"2022","unstructured":"Shakour Z.T.; Farag M.A.; Diverse host-associated fungal systems as a dynamic source of novel bioactive anthraquinones in drug discovery: Current status and future perspectives. J Adv Res  2022,39,257-273","journal-title":"J Adv Res"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"jcp.31063","DOI":"10.1002\/jcp.31063","author":"Wang P.","year":"2023","unstructured":"Wang P.; Wei J.; Hua X.; Dong G.; Dziedzic K.; Wahab A.; Efferth T.; Sun W.; Ma P.; Plant anthraquinones: Classification, distribution, biosynthesis, and regulation. J Cell Physiol  2023,jcp.31063","journal-title":"J Cell Physiol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/B978-0-444-64056-7.00011-8","volume":"58","author":"Diaz-Mu\u00f1oz G.","year":"2018","unstructured":"Diaz-Mu\u00f1oz G.; Miranda I.L.; Sartori S.K.; Rezende D.D.C.; Diaz M.A.N.; Anthraquinones: An overview. Stud Nat Prod Chem  2018,58,313-338","journal-title":"Stud Nat Prod Chem"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"8973","DOI":"10.1039\/D4FO02600D","volume":"15","author":"Dong M.","year":"2024","unstructured":"Dong M.; Ming X.; Xiang T.; Feng N.; Zhang M.; Ye X.; He Y.; Zhou M.; Wu Q.; Recent research on the physicochemical properties and biological activities of quinones and their practical applications: A comprehensive review. Food Funct  2024,15(18),8973-8997","journal-title":"Food Funct"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"126920","DOI":"10.1016\/j.jclepro.2021.126920","volume":"301","author":"Phan K.","year":"2021","unstructured":"Phan K.; Raes K.; Speybroeck V.V.; Roosen M.; Clerck D.K.; Meester D.S.; Non-food applications of natural dyes extracted from agro-food residues: A critical review. J Clean Prod  2021,301,126920","journal-title":"J Clean Prod"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"100449","DOI":"10.1016\/j.ese.2024.100449","volume":"22","author":"Chen C.X.","year":"2024","unstructured":"Chen C.X.; Yang S.S.; Pang J.W.; He L.; Zang Y.N.; Ding L.; Ren N.Q.; Ding J.; Anthraquinones-based photocatalysis: A comprehensive review. Environ Sci Ecotechnol  2024,22,100449","journal-title":"Environ Sci Ecotechnol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"3811","DOI":"10.1002\/cctc.202000376","volume":"12","author":"Cervantes-Gonz\u00e1lez J.","year":"2020","unstructured":"Cervantes-Gonz\u00e1lez J.; Vosburg D.A.; Mora-Rodriguez S.E.; V\u00e1zquez M.A.; Zepeda L.G.; G\u00f3mez V.C.; Lagunas-Rivera S.; Anthraquinones: Versatile organic photocatalysts. ChemCatChem  2020,12(15),3811-3827","journal-title":"ChemCatChem"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"35806","DOI":"10.1039\/D1RA05686G","volume":"11","author":"Malik M.S.","year":"2021","unstructured":"Malik M.S.; Alsantali R.I.; Jassas R.S.; Alsimaree A.A.; Syed R.; Alsharif M.A.; Kalpana K.; Morad M.; Althagafi I.I.; Ahmed S.A.; Journey of anthraquinones as anticancer agents \u2013 a systematic review of recent literature. RSC Advances  2021,11(57),35806-35827","journal-title":"RSC Advances"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1016\/j.drudis.2016.06.027","volume":"21","author":"Baqi Y.","year":"2016","unstructured":"Baqi Y.; Anthraquinones as a privileged scaffold in drug discovery targeting nucleotide-binding proteins. Drug Discov Today  2016,21(10),1571-1577","journal-title":"Drug Discov Today"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"990822","DOI":"10.3389\/fntpr.2022.990822","volume":"1","author":"Preet G.","year":"2022","unstructured":"Preet G.; Gomez-Banderas J.; Ebel R.; Jaspars M.; A structure-activity relationship analysis of anthraquinones with antifouling activity against marine biofilm-forming bacteria. Front Nat Prod  2022,1,990822","journal-title":"Front Nat Prod"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"112202","DOI":"10.1016\/j.ejmech.2020.112202","volume":"195","author":"Roy S.","year":"2020","unstructured":"Roy S.; Ali A.; Kamra M.; Muniyappa K.; Bhattacharya S.; Specific stabilization of promoter G-Quadruplex DNA by 2,6-disubstituted amidoanthracene-9,10-dione based dimeric distamycin analogues and their selective cancer cell cytotoxicity. Eur J Med Chem  2020,195,112202","journal-title":"Eur J Med Chem"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1039\/D3MD00116D","volume":"14","author":"Qun T.","year":"2023","unstructured":"Qun T.; Zhou T.; Hao J.; Wang C.; Zhang K.; Xu J.; Wang X.; Zhou W.; Antibacterial activities of anthraquinones: Structure\u2013activity relationships and action mechanisms. RSC Med Chem  2023,14(8),1446-1471","journal-title":"RSC Med Chem"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.ejmech.2016.10.012","volume":"125","author":"Zheng Y.","year":"2017","unstructured":"Zheng Y.; Zhu L.; Fan L.; Zhao W.; Wang J.; Hao X.; Zhu Y.; Hu X.; Yuan Y.; Shao J.; Wang W.; Synthesis, SAR and pharmacological characterization of novel anthraquinone cation compounds as potential anticancer agents. Eur J Med Chem  2017,125,902-913","journal-title":"Eur J Med Chem"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2174\/1574892813666171206123114","volume":"13","author":"Tikhomirov A.S.","year":"2018","unstructured":"Tikhomirov A.S.; Shtil A.A.; Shchekotikhin A.E.; Advances in the discovery of anthraquinone-based anticancer agents. Rec Pat Anti Drug Discov  2018,13(2),159-183","journal-title":"Rec Pat Anti Drug Discov"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1021\/cr60021a007","volume":"6","author":"Phillips M.","year":"1929","unstructured":"Phillips M.; The chemistry of anthraquinone. Chem Rev  1929,6(1),157-174","journal-title":"Chem Rev"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/B978-0-444-64056-7.00011-8","volume":"58","author":"Diaz-Mu\u00f1oz G.","year":"2018","unstructured":"Diaz-Mu\u00f1oz G.; Miranda I.L.; Sartori S.K.; Rezende D.D.C.; Diaz M.A.N.; Anthraquinones: An overview. Stud Nat Prod Chem  2018,58,313-338","journal-title":"Stud Nat Prod Chem"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1021\/ed007p2609","volume":"7","author":"Fieser L.F.","year":"1930","unstructured":"Fieser L.F.; The discovery of synthetic alizarin. J Chem Educ  1930,7(11),2609","journal-title":"J Chem Educ"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1201\/9781315120157-9","author":"Fouillaud M.","year":"2018","unstructured":"Fouillaud M.; Caro Y.; Venkatachalam M.; Grondin I.; Dufoss\u00e9 L.;  Phenol Comp Food  2018,131-172","journal-title":"Phenol Comp Food"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.4155\/fmc-2019-0198","volume":"12","author":"Siddamurthi S.","year":"2020","unstructured":"Siddamurthi S.; Gutti G.; Jana S.; Kumar A.; Singh S.K.; Anthraquinone: A promising scaffold for the discovery and development of therapeutic agents in cancer therapy. Future Med Chem  2020,12(11),1037-1069","journal-title":"Future Med Chem"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"214","DOI":"10.2174\/157340311799960645","volume":"7","author":"Volkova M.","year":"2012","unstructured":"Volkova M.; Russell R.; Anthracycline cardiotoxicity: Prevalence, pathogenesis and treatment. Curr Cardiol Rev  2012,7(4),214-220","journal-title":"Curr Cardiol Rev"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0165-1218(90)90002-j","volume":"240","author":"Westendorf J","year":"1990","unstructured":"Westendorf J; Marquardt H; Poginsky B; Dominiak M; Schmidt J; Marquardt H; Genotoxicity of naturally occurring hydroxyanthraquinones. Mutat Res Genet Toxicol  1990,240(1),1-2","journal-title":"Mutat Res Genet Toxicol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1016\/j.ejmech.2007.08.009","volume":"43","author":"Cui X.R.","year":"2008","unstructured":"Cui X.R.; Tsukada M.; Suzuki N.; Shimamura T.; Gao L.; Koyanagi J.; Komada F.; Saito S.; Comparison of the cytotoxic activities of naturally occurring hydroxyanthraquinones and hydroxynaphthoquinones. Eur J Med Chem  2008,43(6),1206-1215","journal-title":"Eur J Med Chem"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"6186","DOI":"10.1080\/14786419.2022.2039920","volume":"36","author":"Cheemalamarri C.","year":"2022","unstructured":"Cheemalamarri C.; Batchu U.R.; Thallamapuram N.P.; Katragadda S.B.; Shetty R.P.; A review on hydroxy anthraquinones from bacteria: Crosstalk\u2019s of structures and biological activities. Nat Prod Res  2022,36(23),6186-6205","journal-title":"Nat Prod Res"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1007\/s00044-019-02443-0","volume":"28","author":"Mielczarek-Puta M.","year":"2019","unstructured":"Mielczarek-Puta M.; Struga M.; Roszkowski P.; Synthesis and anticancer effects of conjugates of doxorubicin and unsaturated fatty acids (LNA and DHA). Med Chem Res  2019,28(12),2153-2164","journal-title":"Med Chem Res"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1039\/C6TB00612D","volume":"4","author":"Zhang C.","year":"2016","unstructured":"Zhang C.; Jin S.; Xue X.; Zhang T.; Jiang Y.; Wang P.C.; Liang X.J.; Tunable self-assembly of Irinotecan-fatty acid prodrugs with increased cytotoxicity to cancer cells. J Mater Chem B Mater Biol Med  2016,4(19),3286-3291","journal-title":"J Mater Chem B Mater Biol Med"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1021\/mp4004139","volume":"11","author":"Liang C.","year":"2014","unstructured":"Liang C.; Ye W.; Zhu C.; Na R.; Cheng Y.; Cui H.; Liu D.; Yang Z.; Zhou S.; Synthesis of doxorubicin \u03b1-linolenic acid conjugate and evaluation of its antitumor activity. Mol Pharm  2014,11(5),1378-1390","journal-title":"Mol Pharm"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"e202301502","DOI":"10.1002\/slct.202301502","volume":"8","author":"Mishra B.","year":"2023","unstructured":"Mishra B.; Acharya P.C.; De U.C.; Synthesis and antineoplastic efficacy of anthraquinone and saturated fatty acid conjugates. ChemistrySelect  2023,8(25),e202301502","journal-title":"ChemistrySelect"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.ejmech.2015.08.006","volume":"102","author":"Zhao L.M.","year":"2015","unstructured":"Zhao L.M.; Ma F.Y.; Jin H.S.; Zheng S.; Zhong Q.; Wang G.; Design and synthesis of novel hydroxyanthraquinone nitrogen mustard derivatives as potential anticancer agents via a bioisostere approach. Eur J Med Chem  2015,102,303-309","journal-title":"Eur J Med Chem"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"104395","DOI":"10.1016\/j.bioorg.2020.104395","volume":"107","author":"Lin K.W.","year":"2021","unstructured":"Lin K.W.; Lin W.H.; Su C.L.; Hsu H.Y.; Lin C.N.; Design, synthesis and antitumour evaluation of novel anthraquinone derivatives. Bioorg Chem  2021,107,104395","journal-title":"Bioorg Chem"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1007\/s00044-020-02587-4","volume":"29","author":"Oliveira L.A.","year":"2020","unstructured":"Oliveira L.A.; Nicolella H.D.; Furtado R.A.; Lima N.M.; Tavares D.C.; Corr\u00eaa T.A.; Almeida M.V.; Design, synthesis, and antitumor evaluation of novel anthraquinone derivatives. Med Chem Res  2020,29(9),1611-1620","journal-title":"Med Chem Res"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3390\/cells11010168","volume":"11","author":"Morgan I.","year":"2022","unstructured":"Morgan I.; Wessjohann L.A.; Kalu\u0111erovi\u0107 G.N.; In vitro anticancer screening and preliminary mechanistic study of A-ring substituted Anthraquinone derivatives. Cells  2022,11(1),168","journal-title":"Cells"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.bmcl.2019.02.026","volume":"29","author":"Liu Y.","year":"2019","unstructured":"Liu Y.; Liang Y.; Jiang J.; Qin Q.; Wang L.; Liu X.; Design, synthesis and biological evaluation of 1,4-dihydroxyanthraquinone derivatives as anticancer agents. Bioorg Med Chem Lett  2019,29(9),1120-1126","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"e2000328","DOI":"10.1002\/cbdv.202000328","volume":"17","author":"Li Y.","year":"2020","unstructured":"Li Y.; Guo F.; Chen T.; Zhang L.; Wang Z.; Su Q.; Feng L.; Design, synthesis, molecular docking, and biological evaluation of new emodin anthraquinone derivatives as potential antitumor substances. Chem Biodivers  2020,17(9),e2000328","journal-title":"Chem Biodivers"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ejmech.2019.01.085","volume":"168","author":"Huang K.","year":"2019","unstructured":"Huang K.; Jiang L.; Liang R.; Li H.; Ruan X.; Shan C.; Ye D.; Zhou L.; Synthesis and biological evaluation of anthraquinone derivatives as allosteric phosphoglycerate mutase 1 inhibitors for cancer treatment. Eur J Med Chem  2019,168,45-57","journal-title":"Eur J Med Chem"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"116103","DOI":"10.1016\/j.ejmech.2023.116103","volume":"265","author":"Tikhomirov A.S.","year":"2024","unstructured":"Tikhomirov A.S.; Sinkevich Y.B.; Dezhenkova L.G.; Kaluzhny D.N.; Ilyinsky N.S.; Borshchevskiy V.I.; Schols D.; Shchekotikhin A.E.; Synthesis and antitumor activity of cyclopentane-fused anthraquinone derivatives. Eur J Med Chem  2024,265,116103","journal-title":"Eur J Med Chem"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1007\/s00044-021-02754-1","volume":"30","author":"Sirazhetdinova N.S.","year":"2021","unstructured":"Sirazhetdinova N.S.; Savelyev V.A.; Baev D.S.; Golubeva T.S.; Klimenko L.S.; Tolstikova T.G.; Ganbaatar J.; Shults E.E.; Synthesis, characterization and anticancer evaluation of nitrogen-substituted 1-(3-aminoprop-1-ynyl)-4-hydroxyanthraquinone derivatives. Med Chem Res  2021,30(8),1541-1556","journal-title":"Med Chem Res"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.bmc.2019.02.041","volume":"27","author":"Hu X.","year":"2019","unstructured":"Hu X.; Cao Y.; Yin X.; Zhu L.; Chen Y.; Wang W.; Hu J.; Design and synthesis of various quinizarin derivatives as potential anticancer agents in acute T lymphoblastic leukemia. Bioorg Med Chem  2019,27(7),1362-1369","journal-title":"Bioorg Med Chem"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"104005","DOI":"10.1016\/j.bioorg.2020.104005","volume":"101","author":"Xie X.W.","year":"2020","unstructured":"Xie X.W.; Liu Z.P.; Li X.; Design, synthesis, bioevaluation of LFC- and PA-tethered anthraquinone analogues of mitoxantrone. Bioorg Chem  2020,101,104005","journal-title":"Bioorg Chem"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1021\/acsmedchemlett.8b00624","volume":"10","author":"Tian W.","year":"2019","unstructured":"Tian W.; Li J.; Su Z.; Lan F.; Li Z.; Liang D.; Wang C.; Li D.; Hou H.; Novel anthraquinone compounds induce cancer cell death through paraptosis. ACS Med Chem Lett  2019,10(5),732-736","journal-title":"ACS Med Chem Lett"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"115481","DOI":"10.1016\/j.taap.2021.115481","volume":"418","author":"Li Y.","year":"2021","unstructured":"Li Y.; Guo F.; Chen T.; Zhang L.; Qin Y.; Anthraquinone derivative C10 inhibits proliferation and cell cycle progression in colon cancer cells via the Jak2\/Stat3 signaling pathway. Toxicol Appl Pharmacol  2021,418,115481","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/0223-5234(89)90159-1","volume":"24","author":"Katzhendler J.","year":"1989","unstructured":"Katzhendler J.; Gean K.; Barad G.; Tashma Z.; Benshoshan R.; Ringel I.; Bachrach U.; Ramu A.; Synthesis of aminoanthraquinone derivatives and their in vitro evaluation as potential anti-cancer drugs. Eur J Med Chem  1989,24(1),23-30","journal-title":"Eur J Med Chem"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1248\/cpb.53.1136","volume":"53","author":"Huang H.S.","year":"2005","unstructured":"Huang H.S.; Chiu H.F.; Lu W.C.; Yuan C.L.; Synthesis and antitumor activity of 1,8-diaminoanthraquinone derivatives. Chem Pharm Bull  2005,53(9),1136-1139","journal-title":"Chem Pharm Bull"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1021\/acsomega.1c06125","volume":"7","author":"Banerjee S.","year":"2022","unstructured":"Banerjee S.; Roy S.; Dharumadurai D.; Perumalsamy B.; Thirumurugan R.; Das S.; Chattopadhyay A.P.; Guin P.S.; A Co(III) Complex of 1-Amino-4-hydroxy-9,10-anthraquinone exhibits apoptotic action against MCF-7 human breast cancer cells. ACS Omega  2022,7(1),1428-1436","journal-title":"ACS Omega"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"e202200436","DOI":"10.1002\/cmdc.202200436","volume":"17","author":"Roy S.","year":"2022","unstructured":"Roy S.; Muniyappa K.; Bhattacharya S.; Deciphering the binding insights of novel disubstituted anthraquinone derivatives with G\u2010quadruplex DNA to exhibit selective cancer cell cytotoxicity. Chem Med Chem  2022,17(22),e202200436","journal-title":"Chem Med Chem"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"e140222201110","DOI":"10.2174\/1570163819666220214115408","volume":"19","author":"Acharya P.C.","year":"2022","unstructured":"Acharya P.C.; Debbarma S.; Targeting G-quadruplex DNA for cancer chemotherapy. Curr Drug Discov Technol  2022,19(3),e140222201110","journal-title":"Curr Drug Discov Technol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"6156","DOI":"10.1016\/j.bmcl.2013.09.004","volume":"23","author":"Sangthong S.","year":"2013","unstructured":"Sangthong S.; Ha H.; Teerawattananon T.; Ngamrojanavanich N.; Neamati N.; Muangsin N.; Overcoming doxorubicin-resistance in the NCI\/ADR-RES model cancer cell line by novel anthracene-9,10-dione derivatives. Bioorg Med Chem Lett  2013,23(22),6156-6160","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"5670","DOI":"10.1016\/j.bmc.2011.07.021","volume":"19","author":"Tu H.Y.","year":"2011","unstructured":"Tu H.Y.; Huang A.M.; Teng C.H.; Hour T.C.; Yang S.C.; Pu Y.S.; Lin C.N.; Anthraquinone derivatives induce G2\/M cell cycle arrest and apoptosis in NTUB1 cells. Bioorg Med Chem  2011,19(18),5670-5678","journal-title":"Bioorg Med Chem"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.ejmech.2010.11.017","volume":"46","author":"Shchekotikhin A.E.","year":"2011","unstructured":"Shchekotikhin A.E.; Glazunova V.A.; Dezhenkova L.G.; Shevtsova E.K.; Traven\u2019 V.F.; Balzarini J.; Huang H.S.; Shtil A.A.; Preobrazhenskaya M.N.; The first series of 4,11-bis[(2-aminoethyl)amino]anthra[2,3-b]furan-5,10-diones: Synthesis and anti-proliferative characteristics. Eur J Med Chem  2011,46(1),423-428","journal-title":"Eur J Med Chem"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.ejmech.2011.10.059","volume":"47","author":"Lee C.C.","year":"2012","unstructured":"Lee C.C.; Huang K.F.; Lin P.Y.; Huang F.C.; Chen C.L.; Chen T.C.; Guh J.H.; Lin J.J.; Huang H.S.; Synthesis, antiproliferative activities and telomerase inhibition evaluation of novel asymmetrical 1,2-disubstituted amidoanthraquinone derivatives. Eur J Med Chem  2012,47(1),323-336","journal-title":"Eur J Med Chem"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s12272-013-0074-x","volume":"36","author":"Taher A.T.","year":"2013","unstructured":"Taher A.T.; Hegazy G.H.; Synthesis of novel bis-anthraquinone derivatives and their biological evaluation as antitumor agents. Arch Pharm Res  2013,36(5),573-578","journal-title":"Arch Pharm Res"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.ejmech.2015.07.052","volume":"102","author":"Lee Y.R.","year":"2015","unstructured":"Lee Y.R.; Chen T.C.; Lee C.C.; Chen C.L.; Ali A.A.A.; Tikhomirov A.; Guh J.H.; Yu D.S.; Huang H.S.; Ring fusion strategy for synthesis and lead optimization of sulfur-substituted anthra[1,2-c][1,2,5]thiadiazole-6,11-dione derivatives as promising scaffold of antitumor agents. Eur J Med Chem  2015,102,661-676","journal-title":"Eur J Med Chem"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1007\/s11030-020-10142-x","volume":"25","author":"Mohamadzadeh M.","year":"2021","unstructured":"Mohamadzadeh M.; Zarei M.; Anticancer activity and evaluation of apoptotic genes expression of 2-azetidinones containing anthraquinone moiety. Mol Divers  2021,25(4),2429-2439","journal-title":"Mol Divers"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.molstruc.2018.07.070","volume":"1175","author":"Niedzia\u0142kowski P.","year":"2019","unstructured":"Niedzia\u0142kowski P.; Czaczyk E.; Jarosz J.; Wcis\u0142o A.; Bia\u0142obrzeska W.; Wietrzyk J.; Ossowski T.; Synthesis and electrochemical, spectral, and biological evaluation of novel 9,10-anthraquinone derivatives containing piperidine unit as potent antiproliferative agents. J Mol Struct  2019,1175,488-495","journal-title":"J Mol Struct"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"100996","DOI":"10.1016\/j.rechem.2023.100996","volume":"6","author":"Arrousse N.","year":"2023","unstructured":"Arrousse N.; Harras M.F.; Kadiri E.S.; Haldhar R.; Ichou H.; Bousta D.; Grafov A.; Rais Z.; Taleb M.; New anthraquinone drugs and their anticancer activities: Cytotoxicity, DFT, docking and ADMET properties. Results Chem  2023,6,100996","journal-title":"Results Chem"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"113521","DOI":"10.1016\/j.ejmech.2021.113521","volume":"221","author":"Volodina Y.L.","year":"2021","unstructured":"Volodina Y.L.; Tikhomirov A.S.; Dezhenkova L.G.; Ramonova A.A.; Kononova A.V.; Andreeva D.V.; Kaluzhny D.N.; Schols D.; Moisenovich M.M.; Shchekotikhin A.E.; Shtil A.A.; Thiophene-2-carboxamide derivatives of anthraquinone: A new potent antitumor chemotype. Eur J Med Chem  2021,221,113521","journal-title":"Eur J Med Chem"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"174020","DOI":"10.1016\/j.ejphar.2021.174020","volume":"900","author":"Lin S.","year":"2021","unstructured":"Lin S.; Zhang Y.; Wang Z.; Zhang S.; Li Y.; Fan Y.; Li D.; Li S.; Bai Y.; Preparation of novel anthraquinone-based aspirin derivatives with anti-cancer activity. Eur J Pharmacol  2021,900,174020","journal-title":"Eur J Pharmacol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.biochi.2020.12.024","volume":"182","author":"Singh M.","year":"2021","unstructured":"Singh M.; Malhotra L.; Haque M.A.; Kumar M.; Tikhomirov A.; Litvinova V.; Korolev A.M.; Ethayathulla A.S.; Das U.; Shchekotikhin A.E.; Kaur P.; Heteroarene-fused anthraquinone derivatives as potential modulators for human aurora kinase B. Biochimie  2021,182,152-165","journal-title":"Biochimie"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.1016\/j.arabjc.2015.06.017","volume":"12","author":"Chen T.C.","year":"2019","unstructured":"Chen T.C.; Guh J.H.; Hsu H.W.; Chen C.L.; Lee C.C.; Wu C.L.; Lee Y.R.; Lin J.J.; Yu D.S.; Huang H.S.; Synthesis and biological evaluation of anthra[1,9-cd]pyrazol-6(2H)-one scaffold derivatives as potential anticancer agents. Arab J Chem  2019,12(8),2864-2881","journal-title":"Arab J Chem"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"105925","DOI":"10.1016\/j.bioorg.2022.105925","volume":"127","author":"Tikhomirov A.S.","year":"2022","unstructured":"Tikhomirov A.S.; Tsvetkov V.B.; Volodina Y.L.; Litvinova V.A.; Andreeva D.V.; Dezhenkova L.G.; Kaluzhny D.N.; Treshalin I.D.; Shtil A.A.; Shchekotikhin A.E.; Heterocyclic ring expansion yields anthraquinone derivatives potent against multidrug resistant tumor cells. Bioorg Chem  2022,127,105925","journal-title":"Bioorg Chem"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.2174\/092986707781058805","volume":"14","author":"Claudio Viegas-Junior","year":"2007","unstructured":"Claudio Viegas-Junior ; Danuello A.; da Silva Bolzani V.; Barreiro E.J.; Fraga C.A.; Molecular hybridization: A useful tool in the design of new drug prototypes. Curr Med Chem  2007,14(17),1829-1852","journal-title":"Curr Med Chem"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1517\/17460441.2016.1135125","volume":"11","author":"B\u00e9rub\u00e9 G.","year":"2016","unstructured":"B\u00e9rub\u00e9 G.; An overview of molecular hybrids in drug discovery. Expert Opin Drug Discov  2016,11(3),281-305","journal-title":"Expert Opin Drug Discov"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1080\/17460441.2021.1850686","volume":"16","author":"Shalini K.V.","year":"2021","unstructured":"Shalini K.V.; Kumar V.; Have molecular hybrids delivered effective anti-cancer treatments and what should future drug discovery focus on? Expert Opin Drug Discov  2021,16(4),335-363","journal-title":"Expert Opin Drug Discov"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"e181","DOI":"10.1002\/mco2.181","volume":"3","author":"Liu G.H.","year":"2022","unstructured":"Liu G.H.; Chen T.; Zhang X.; Ma X.L.; Shi H.S.; Small molecule inhibitors targeting the cancers. MedComm  2022,3(4),e181","journal-title":"MedComm"},{"key":"ref=66","first-page":"1","author":"Decker M.","year":"2017","unstructured":"Decker M.;  Ed; In Design of hybrid molecules for drug development  2017,1-338","journal-title":"Ed; In Design of hybrid molecules for drug development"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"113768","DOI":"10.1016\/j.ejmech.2021.113768","volume":"225","author":"Soltan O.M.","year":"2021","unstructured":"Soltan O.M.; Shoman M.E.; Abdel-Aziz S.A.; Narumi A.; Konno H.; Abdel-Aziz M.; Molecular hybrids: A five-year survey on structures of multiple targeted hybrids of protein kinase inhibitors for cancer therapy. Eur J Med Chem  2021,225,113768","journal-title":"Eur J Med Chem"},{"key":"ref=68","first-page":"239","author":"Fujii H.","year":"2011","unstructured":"Fujii H.;  Chemistry of Opioids  2011,239-275","journal-title":"Chemistry of Opioids"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/B978-0-12-374194-3.00027-5","author":"Morphy R.","year":"2008","unstructured":"Morphy R.; Rankovic Z.; Multi-target drugs: Strategies and challenges for medicinal chemists. The Prac Med Chem; Elsevier:  2008,549-571","journal-title":"The Prac Med Chem; Elsevier:"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"6632","DOI":"10.3390\/molecules27196632","volume":"27","author":"Sflakidou E.","year":"2022","unstructured":"Sflakidou E.; Leonidis G.; Foroglou E.; Siokatas C.; Sarli V.; Recent advances in natural product-based hybrids as anti-cancer agents. Molecules  2022,27(19),6632","journal-title":"Molecules"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/1439-7633(20001117)1:4<281::AID-CBIC281>3.0.CO;2-W","volume":"1","author":"Dechy-Cabaret O.","year":"2000","unstructured":"Dechy-Cabaret O.; Benoit-Vical F.; Robert A.; Meunier B.; Preparation and antimalarial activities of \u201ctrioxaquines\u201d, new modular molecules with a trioxane skeleton linked to a 4-aminoquinoline. Chem Bio Chem  2000,1(4),281-283","journal-title":"Chem Bio Chem"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"22580","DOI":"10.3390\/ijms151222580","volume":"15","author":"Almutairi M.","year":"2014","unstructured":"Almutairi M.; Hegazy G.; Haiba M.; Ali H.; Khalifa N.; Soliman A.; Synthesis, docking and biological activities of novel hybrids celecoxib and anthraquinone analogs as potent cytotoxic agents. Int J Mol Sci  2014,15(12),22580-22603","journal-title":"Int J Mol Sci"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.ejmech.2014.10.055","volume":"89","author":"Markovi\u0107 V.","year":"2015","unstructured":"Markovi\u0107 V.; Debeljak N.; Stanojkovi\u0107 T.; Kolund\u017eija B.; Sladi\u0107 D.; Vuj\u010di\u0107 M.; Janovi\u0107 B.; Tani\u0107 N.; Perovi\u0107 M.; Te\u0161i\u0107 V.; Anti\u0107 J.; Joksovi\u0107 M.D.; Anthraquinone\u2013chalcone hybrids: Synthesis, preliminary antiproliferative evaluation and DNA-interaction studies. Eur J Med Chem  2015,89,401-410","journal-title":"Eur J Med Chem"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"10871","DOI":"10.1016\/S0040-4020(97)00693-5","volume":"53","author":"Riccardis D.F.","year":"1997","unstructured":"Riccardis D.F.; Izzo I.; Filippo D.M.; Sodano G.; D\u2019Acquisto F.; Carnuccio R.; Synthesis and cytotoxic activity of steroid-anthraquinone hybrids. Tetrahedron  1997,53(31),10871-10882","journal-title":"Tetrahedron"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4155\/fmc-2019-0230","volume":"12","author":"Liang D.","year":"2020","unstructured":"Liang D.; Su Z.; Tian W.; Li J.; Li Z.; Wang C.; Li D.; Hou H.; Synthesis and screening of novel anthraquinone-quinazoline multitarget hybrids as promising anticancer candidates. Future Med Chem  2020,12(2),111-126","journal-title":"Future Med Chem"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.compbiolchem.2016.12.005","volume":"67","author":"Arba M.","year":"2017","unstructured":"Arba M.; Ihsan S.; Ramadhan L.O.A.N.; Tjahjono D.H.; In silico study of porphyrin-anthraquinone hybrids as CDK2 inhibitor. Comput Biol Chem  2017,67,9-14","journal-title":"Comput Biol Chem"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1007\/s00044-023-03157-0","volume":"32","author":"Long X.","year":"2023","unstructured":"Long X.; Yang P.; Chen L.; Zhong W.; Chen S.; Li Y.; Lin S.; Tian W.; Novel aloe emodin\u2013hydroxyethyl piperazine hybrid dihydrochloride induces oral cancer CAL-27 cells apoptosis through ROS production, DNA damage and mitochondrial pathways. Med Chem Res  2023,32(12),2549-2561","journal-title":"Med Chem Res"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"6986","DOI":"10.1021\/cr4002935","volume":"114","author":"Bansal R.","year":"2014","unstructured":"Bansal R.; Acharya P.C.; Man-made cytotoxic steroids: Exemplary agents for cancer therapy. Chem Rev  2014,114(14),6986-7005","journal-title":"Chem Rev"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"6095","DOI":"10.1111\/febs.15583","volume":"288","author":"van der Zanden S.Y.","year":"2021","unstructured":"van der Zanden S.Y.; Qiao X.; Neefjes J.; New insights into the activities and toxicities of the old anticancer drug doxorubicin. FEBS J  2021,288(21),6095-6111","journal-title":"FEBS J"}],"container-title":["Anti-Cancer Agents in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0118715206374787250227064528","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/239948\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0118715206374787250227064528","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T04:43:29Z","timestamp":1753245809000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/239948\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":79,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0118715206374787250227064528","relation":{},"ISSN":["1871-5206"],"issn-type":[{"value":"1871-5206","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-11-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-28","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}